|
2024
|
P/S
|
Pharmaceutical preparations; reagent paper for medical
purposes; deodorants, except deodorants f... |
|
2023
|
Invention
|
Lipocalin-type prostaglandin d2 synthase production promoting agent.
A lipocalin-type prostaglan... |
|
|
Invention
|
Therapeutic agent for nervous system disease. 12 as an active ingredient according to the present... |
|
|
Invention
|
Program, information processing device, and information processing method. Provided is a program ... |
|
2021
|
Invention
|
Agent for promoting expression of n-acetylgalactosaminyltransferase containing extract from infla... |
|
|
Invention
|
Formulation for oral administration.
An oral preparation contains tramadol or a pharmaceutically... |
|
|
Invention
|
Method for producing granulated substance. The present invention addresses the problem of providi... |
|
|
Invention
|
Formulation for oral administration. The present invention addresses the problem of providing an ... |
|
|
Invention
|
Liquid medicine composition. The present invention addresses the problem of providing an orally a... |
|
|
Invention
|
Method for culturing cell population containing cartilage-derived tie2-positive cells and use of ... |
|
|
Invention
|
Method for culturing cell population containing cartilage-derived tie2-positive cells, and use of... |
|
|
Invention
|
Method for manufacturing acetaminophen preparation. A method for manufacturing a preparation whic... |
|
|
Invention
|
Sustained drug release sheet for treating nerve injury. A sustained release sheet that includes a... |
|
|
Invention
|
Medical sheet.
A medical sheet has a cell infiltration suppressing action, including a nonwoven ... |
|
|
Invention
|
Medical sheet. The present invention provides a medical sheet which comprises nonwoven fabric for... |
|
2020
|
Invention
|
Method for culturing tie2-positive stem/progenitor cell-containing cell population using culture ... |
|
|
Invention
|
Method for inhibiting the expression of inflammation promoting factors. Provided are an expressio... |
|
|
Invention
|
Therapeutic agent for nervous system disease. 12. |
|
|
Invention
|
Preventive or therapeutic agent for muscle injury.
The purpose of the present invention is to pr... |
|
|
Invention
|
Agent for promoting migration of pluripotent stem cells.
An agent for promoting migration of plu... |
|
|
Invention
|
Method of culturing cell population and use thereof.
Preparing a cell population rich in cells h... |
|
|
Invention
|
Method for culturing cell population and use thereof. The present invention addresses the problem... |
|
2019
|
Invention
|
Particulate composition and production method therefor. The present invention provides: a particu... |
|
|
Invention
|
Nonwoven fabric, method for manufacturing same, and composition for electrospinning. A non-woven ... |
|
|
Invention
|
Nonwoven fabric, method for manufacturing same, and composition for electrospinning. The present ... |
|
|
Invention
|
Processing method for drug substance particles of non-uniform particle size.
The present inventi... |
|
|
Invention
|
Processing method for raw drug particles of non-uniform particle size. The present invention rela... |
|
|
Invention
|
Il-17a activity inhibitor and use thereof.
A low-molecular-weight compound (IL-17 activity inhib... |
|
|
Invention
|
Il-17a activity inhibitor and use thereof. The present invention addresses the problem of providi... |
|
|
Invention
|
Inhibiting or alleviating agent for inflammation in the brain.
An inhibiting or alleviating agen... |
|
|
Invention
|
Inhibiting or alleviating agent for inflammation in the brain. An inhibiting or alleviating agent... |
|
2018
|
Invention
|
Lipocalin-type prostaglandin d2 synthase production accelerating agent. The purpose of the presen... |
|
|
Invention
|
Agent for treatment of nervous system disease. 1212 as an active ingredient, has an action of pro... |
|
|
Invention
|
Extract and formulation including extract. It is an object of the present invention to provide an... |
|
|
Invention
|
Method for inhibiting the expression of cancer-promoting factors. Provided are an expression inhi... |
|
|
Invention
|
Inhibitor of the expression of cancer-promoting factors, screening method for active ingredient t... |
|
|
Invention
|
Acetaminophen preparation, and method for producing same. A preparation which contains acetaminop... |
|
|
Invention
|
Acetaminophen preparation, and method for producing same. The present invention addresses the pro... |
|
|
Invention
|
Carcinogenesis inhibitor. A carcinogenesis inhibitor having no side effect and having an excellen... |
|
|
Invention
|
Carcinogenesis inhibitor. The purpose of the present invention is to provide a carcinogenesis inh... |
|
2017
|
Invention
|
Schwann cell differentiation promoting agent and a peripheral nerve regeneration promoting agent.... |
|
|
Invention
|
Expression inhibitor of inflammation promoting factor, screening method for active ingredient the... |
|
|
Invention
|
Prostaglandin derivative. The present invention relates to a novel prostaglandin derivative havin... |
|
|
Invention
|
Inhibiting or alleviating agent for aβ-induced damage. An inhibiting or alleviating agent for amy... |
|
|
Invention
|
Sustained drug release sheet for treating nerve injury. Provided is a sustained release sheet tha... |
|
|
Invention
|
Test method. The object of the present invention is to provide a test method using a novel admini... |
|
|
Invention
|
Preventive or therapeutic agent for muscle injury.
A medicament is useful for prevention or trea... |
|
1999
|
P/S
|
Pharmaceutical preparation for use in the treatment of pain, neuralgia, [ pruritus, allergic dise... |
